IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oracle Investment Management Inc

Q3 2018 Holdings

Filed 2018-11-14 | 19 holdings | $14.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adaptimmune Therapeutics PLC(ADAPY)SPONDS ADR00653A107$12.2M897,49481.9%
Biogen Inc(BIIB)COM09062X103$2.3M6,36815.1%
Quidel CorpCOM74838J101$124.1K1,903,5580.8%
Accelerate Diagnostics IncCOM00430H102$96.1K4,187,1450.6%
Amarin Corp PLCSPONS ADR NEW023111206$95.2K5,850,1510.6%
Pacific Biosciences Calif in(PACB)COM69404D108$50.8K9,387,6340.3%
Tesaro IncCOM881569107$20.2K517,2350.1%
Biolase IncCOM NEW090911207$12.8K6,173,2500.1%
Opko Health Inc(OPK)COM68375N103$12.8K3,686,1940.1%
Contrafect Corp(CFRXEUR)COM212326102$8.8K4,250,3840.1%
Vermillion IncCOM NEW92407M206$7.0K9,825,2890.0%
Soleno Therapeutics IncCOM NEW834203200$5.3K2,438,0600.0%
Agenus Inc(AGENEUR)COM NEW00847G705$3.2K1,499,5400.0%
Accelerate Diagnostics IncCallCOM00430H102$3.0K967,9000.0%
Viewray Inc(VRAYQ)COM92672L107$2.0K216,8620.0%
Aduro Biotech Inc(ADROEUR)COM00739L101$820111,5420.0%
Epizyme Inc(EPZMEUR)COM29428V104$30628,8840.0%
Quidel CorpCallCOM74838J101$58175,0000.0%
Pacific Biosciences Calif in(PACB)CallCOM69404D108$4650,0000.0%